Stocks
Intellia Therapeutics (NTLA) OCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -103.2 | -49.9 | -225.0 | -333.3 | -394.1 | -356.7 | ||
| Changes by years, y/y, % | +69% | -52% | +351% | +48% | +18% | +45.1% | |||
Intellia Therapeutics. OCF, bln rub
Intellia Therapeutics. OCF, changes, %
Intellia Therapeutics. OCF, sum by quarters, bln rub
Intellia Therapeutics (NTLA) OCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| OCF, bln rub | ? | -101.4 | -93.1 | -120.7 | -58.2 | -84.8 | -356.7 | |
| Changes by years, y/y, % | +29% | +4% | +10% | -36% | -16% | |||
| Changes by quarters, q/q, % | +12% | -8% | +30% | -52% | +46% | |||
